loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 25748 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Blue-Zone Technologies LTD.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Aspen API. More than just an API.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Blue-Zone Technologies LTD. (1)

    filter

    01 DESFLURANE USP (1)

    filter

    01 Canada (1)

    filter

    01 Active (1)

    filter

    01 Blank (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    BLUE ZONE TECHNOLOGIES LTD

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Canada
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      DESFLURANE USP

      PDF Supplier PDF
      URL Supplier Web Content
      25748
      Active
      2012-01-30
      N/A
      II
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Drug Master Files (DMF) for 25748 of Blue Zone Technologies Ltd

      Looking for Drug Master Files (DMF) for 25748 of Blue Zone Technologies Ltd 1

      20

      Blue Zone Technologies Ltd, based in Canada, is a pharmaceutical company.

      One of their notable products is DESFLURANE USP, with a corresponding US DMF Number 25748.

      Remarkably, this DMF maintains an Active status since its submission on January 30, 2012, highlighting commitment to regulatory compliance.

      Post Enquiry
      POST ENQUIRY